The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survival. van Eijck CWF, Ju J, van 't Land FR, Verheij M, et al. Pancreatology 2024 Aug 22:S1424-3903(24)00711-7. doi: 10.1016/j.pan.2024.

Read + Share

Amedeo Smart

Independent Medical Education

van Eijck CWF, Ju J, van 't Land FR, Verheij M, et al. The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survival. Pancreatology 2024 Aug 22:S1424-3903(24)00711-7. doi: 10.1016/j.pan.2024.
PMID: 39218754